Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Akzo Nobel Receives Offer for Organon Teknika's Diagnostics Business.


Business Editors

ARNHEM, the Netherlands--(BUSINESS WIRE)--Feb. 14, 2001

Akzo Nobel Akzo Nobel is a multinational company, active in the fields of healthcare products, coatings and chemicals. Headquartered in Amsterdam, the Netherlands, the company has activities in more than 80 countries, and employs approximately 62,000 people.  announces that it has received an offer from bioMerieux S.A. for Organon or·ga·non or or·ga·num
n. pl. or·ga·nons or or·ga·nums or or·ga·na
1. An organ.

2. A set of principles for use in scientific investigation.



organon

pl. organa [Gr.] organ.
 Teknika's in vitro diagnostics In vitro diagnostic (IVD) tests are medical tests conducted in a test tube, or more generally in a controlled environment outside a living organism. In vitro means in glass in Latin.  business.

Organon Teknika's diagnostics business has successfully developed a strong worldwide position for specific diagnostic product lines and services, based on its own, specialized R&D capabilities. However, given the strong consolidation in the highly competitive diagnostics market, the company has been actively looking for Looking for

In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with.
 ways of broadening its competitive basis and increasing critical mass in both R&D and international marketing.

"The Board of Management will review the offer, which appears to be attractive and in line with the strategy of our Pharma Group. bioMerieux S.A., part of the bioMerieux-Pierre Fabre group, is a well known and also strongly innovative player in the diagnostic field, and appears to offer a good fit with Organon Teknika's diagnostics business," an Akzo Nobel spokesman said, adding that the two companies had successfully worked together before, in North America.

Employee representative bodies and unions have been informed about the offer and consultation procedures will commence shortly, where applicable. The required regulatory approvals will be sought as and when appropriate.

Akzo Nobel is being advised by Deutsche Bank.

Note for the editor

Organon Teknika, headquartered in Boxtel, the Netherlands, specializes in the R&D, manufacturing and marketing of advanced systems and products for hospitals, laboratories and blood banks. The company currently employs around 2,200 people and is active in more than 60 countries.

Organon Teknika is a business unit of Akzo Nobel. Akzo Nobel, based in the Netherlands, serves customers throughout the world with healthcare products, coatings and chemicals. Consolidated sales for 2000 will total some EUR EUR

In currencies, this is the abbreviation for the Euro.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 14 billion (USD USD

In currencies, this is the abbreviation for the U.S. Dollar.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 13 billion, GBP GBP

In currencies, this is the abbreviation for the British Pound.

Notes:
The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion.
 8.5 billion). The Company currently employs 68,000 people in 75 countries. Financial results for the year 2000 will be announced on February 23, 2001.

bioMerieux S.A., which has its headquarters near Lyon, France, is an in vitro diagnostics company that focuses on infectious disease Infectious disease

A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions.
. bioMerieux's products are used for medical diagnosis, but also for quality control of food, cosmetics and therapeutics, and for environmental testing. In 1999 bioMerieux's sales were approximately EUR 518 million (FRF FRF

The ISO 4217 currency code for the French Franc.
 3.4 billion), making it the eighth largest in vitro diagnostics company in the world.

Internet: http://www.akzonobel.com

http://www.organonteknika.com

http://www.biomerieux.fr

------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/02/14/20010214BIT00570/bit0002.doc http://www.bit.se/bitonline/2001/02/14/20010214BIT00570/bit0002.pdf
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUNE
Date:Feb 14, 2001
Words:437
Previous Article:Tensilica Opens Stockholm Sales Office, Appoints Northern European Sales Manager; New Operation headed by Ola Qvist.
Next Article:ADVISORY/Motorcycles Rumble Through Atlanta!; Did You Know That Overall Motorcycle Sales Are Up 20%?
Topics:



Related Articles
Akzo Nobel Acquires Ethical Pharmaceutical Business of Japanese Kanebo.
Organon Teknika Obtains Exclusive Rights of Analgesic Compound.
Panacea Pharmaceuticals, Inc. Announces Appointment of Chief Patent Counsel.
[0] Akzo Nobel Receives Offer for Organon Teknika's Diagnostics Business.
AKZO NOBEL'S DIOSYNTH ESTABLISHING U.S. BRIDGEHEAD.
Akzo Nobel's Pharma On Course for Double-Digit Growth.
Organon to consult with FDA on Ariza -gepirone ER-.
Organon USA sells portion of West Orange headquarters.
Akzo Nobel makes bid for Sico Inc.
Akzo Nobel plans creation of two entities, Board changes.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles